About 2 Million Updated mRNA COVID-19 Vaccines Administered
According to Reuters reporting, about 1.8 million people in the United States received an updated mRNA COVID-19 vaccine during the week ended September 22, 2023, according to data compiled by IQVIA Holdings Inc.
Moderna Inc. and Pfizer, Inc.'s newly approved vaccines are meeting pent-up consumer demand who are preparing for the forthcoming respiratory disease season in the U.S.
These mRNA vaccines are generally available in U.S.-based pharmacies and health clinics.
As of October 2, 2023, U.S. agencies have not approved Novavax Inc.'s protein-based COVID-19 Vaccine Adjuvanted (Nuvaxovid™).
These innovative vaccines aspire to prevent the fading COVID-19 pandemic from further impacting the global society.